Enhancement of effects of irradiation by gemcitabine in a glioblastoma cell line and cell line spheroids

Journal of Cancer Research and Clinical Oncology

Volumn 130, Issue 1, 2004, Pages 45-51

  Genç, Mine ^a,b   Kreder, Natasja Castro ^a   Barten Van Rijbroek, Angelique ^a   Stalpers, Lukas J A ^a   Haveman, Jaap ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

Gemcitabine; Glioma; Irradiation; Spheroid

Indexed keywords

GEMCITABINE;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER RADIOTHERAPY; CELL ASSAY; CELL SUSPENSION; CHEMOSENSITIVITY; CLONAL VARIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; MONOLAYER CULTURE; MULTICELLULAR SPHEROID; PRIORITY JOURNAL; RADIOSENSITIVITY; TUMOR BIOPSY;

ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; DEOXYCYTIDINE; GLIOBLASTOMA; HUMANS; RADIATION-SENSITIZING AGENTS; SPHEROIDS, CELLULAR;

EID: 0742304070     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-003-0506-y     Document Type: Article

References (40)

1. Arning M, Blatter J (1997) Gemcitabine in solid tumors-present status and further development. Oncologie 29:297-304
2. Barendsen GW (1982) Radiobiology of neutrons. Int J Radiat Oncol Biol Phys 8:2103-2107
3. Barendsen GW, Van Bree C, Franken NA (2001) Importance of cell proliferative state and potentially lethal damage repair on radiation effectiveness: implications for combined tumor treatments. Int J Oncol 19:247-256
4. Biaglow JE, Varnes ME, Jacobson B, Koch CJ (1983) Factors influencing the oxygen consumption and radiation response of cultured mammalian cells. Adv Exp Med Biol 159:347-358
5. Bjerkvig R, Tonnesen A, Laerum OD, Backlund EO (1990) Multicellular tumor spheroids from human gliomas maintained in organ culture. J Neurosurg 72:463-475
6. Buffa FM, West C, Byrne K, Moore JV, Nahum AE (2001) Radiation response and cure rate of human colon adenocarcinoma spheroids of different size: the significance of hypoxia on tumor control modelling. Int J Radiat Oncol Biol Phys 49:1109-1118
7. Carlsson J, Nilsson K, Westermark B, Ponten J, Sundstrom C, Larsson E, Bergh J, Pahlman S, Busch C, Collins VP (1983) Formation and growth of multicellular spheroids of human origin. Int J Cancer 31:523-533
8. Carlsson J, Yuhas JM (1984) Liquid-overlay culture of cellular spheroids. In: Acker H, Carlsson J, Durand R, Sutherland RM (eds) Recent results in cancer research. Spheroids in cancer research. Springer, Berlin, pp 1-23
9. Dertinger H, Hulser D (1981) Increased radioresistance of cells in cultured multicell spheroids. I. Dependence on cellular interaction. Radiat Environ Biophys 19:101-107
10. Desoize B, Gimonet D, Jardiller JC (1998) Cell culture as spheroids: an approach to multicellular resistance. Anticancer Res 18:4147-4158
11. Durand RE, Biaglow JE (1977) Radiosensitization of hypoxic cells of an in vitro tumor model by respiratory inhibitors. Radiat Res 69:359-366
12. Fehlauer F, Barten-Van Rijbroek AD, Stalpers LJ, Leenstra S, Lindeman J, Tjahja I, Troost D, Wolbers JG, van der Valk P, Sminia P (2000) Additive cytotoxic effect of cisplatin and X-irradiation on human glioma cell cultures derived from biopsy-tissue. J Cancer Res Clin Oncol 126:711-716
13. Gertler SZ, MacDonald D, Goodyear M, Forsyth P, Stewart DJ, Belanger K, Perry J, Fulton D, Steward W, Wainman N, Seymour L (2000) NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94). Ann Oncol 11:315-318
14. Gonzàlez Gonzàlez D, Hulshof MCCM (1993) Radiotherapy. In: Twijnstra A, Keyser A, Ongerboer de Visser BW (eds) Neurooncology. Primary tumors and neurological complications of cancer. Elsevier, Amsterdam, pp 134-158
15. Gorlach A, Acker H (1994) pO2- and pH-gradients in multicellular spheroids and their relationship to cellular metabolism and radiation sensitivity of malignant human tumor cells. Biochim Biophys Acta 1227:105-112
16. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
17. Hulshof MC, Koot RW, Schimmel EC, Dekker F, Bosch DA, Gonzalez Gonzalez D (2001) Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution. Strahlenther Onkol 177:283-290
18. Kaaijk P, Troost D, Das PK, Leenstra S, Bosch DA (1995) Long-term culture of organotypic multicellular glioma spheroids: a good culture model for studying gliomas. Neuropathol Appl Neurobiol 21:386
19. Kaaijk P, Troost D, Sminia P, Hulshof MC, van der Kracht AH, Leenstra S, Bosch DA (1997) Hypofractionated radiation induces a decrease in cell proliferation but no histological damage to organotypic multicellular spheroids of human glioblastomas. Eur J Cancer 33:645-651
20. Kunz-Schughart LA (1999) Multicellular tumor spheroids: intermediates between monolayer culture and in vivotumor. Cell Biol Int 23:157-161
21. Latz D, Fleckenstein K, Eble M, Blatter J, Wannenmacher M, Weber KJ (1998) Radiosensitizing potential of gemcitabine (2′,2′-difluoro- 2′-deoxycytidine) within the cell cycle in vitro. Int J Radiat Oncol Biol Phys 41:875-882
22. Lawrence TS, Eisbruch A, Shewach DS (1997) Gemcitabine-mediated radiosensitization. Sem Oncol 24:24-28
23. Mason KA, Milas L, Hunter NR et al. (1999) Maximizing therapeutic gain with gemcitabine and fractionated radiation. Int J Radiat Oncol Biol Phys 44:1125-1135
24. Neshasteh-Riz A, Angerson WJ, Reeves JR, Smith G, Rampling R, Mairs RJ (1997) Incorporation of iododeoxyuridine in multicellular glioma spheroids: implications for DNA-targeted radiotherapy using Auger electron emitters. Br J Cancer 75:493-499
25. Nirmala C, Rao JS, Ruifrok AC, Langford LA, Obeyesekere M. (2001) Growth characteristics of glioblastoma spheroids. Int J Oncol 19:1109-1115
26. Olive PL, Durand RE (1994) Drug and radiation resistance in spheroids: cell contact and kinetics. Cancer Metastasis Rev 13:121-138
27. Ostruszka LJ, Shewach DS (2000) The role of cell cycle progression in radiosensitization by 2′,2′-difluoro-2′-deoxycytidine. Cancer Res 60:6080-6088
28. Plunkett W, Huang P, Gandhi V (1995) Preclinical characteristics of gemcitabine. Anti-Cancer Drugs 6:7-13
29. Prados MD, Wilson CB (1997) Neoplasms of the central nervous system. In: I. Williams & Wilkins (eds) Cancer medicine. Baltimore, pp 1471-1514
30. Ramsay J, Ward R, Bleehen NM (1992) Radiosensitivity testing of human malignant gliomas. Int J Radiat Oncol Biol Phys 24:675-680
31. Rieger J, Durka S, Streffer J, Dichgans J, Weller M (1999) Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone. Eur J Pharmacol 365:301-308
32. Santini MT, Rainaldi G, Indovina PL (1999) Multicellular tumour spheroids in radiation biology. Int J Radiat Biol 1999 75:787-799
33. Sminia P, Acker H, Eikesdal HP, Kaaijk P, Enger P, Slotman B, Bjerkvig R (2003) Oxygenation and response to irradiation of organotypic multicellular spheroids of human glioma. Anticancer Res 23:1461-1466
34. Smitskamp-Wilms E, Pinedo HM, Veerman G, Ruiz van Haperen VWT, Peters GJ (1998) Postconfluent multilayered cell line cultures for selective screening of gemcitabine. Eur J Cancer 34:921-926
35. Sutherland RM & Durand RE (1973) Hypoxic cells in an in vitro tumour model. Int J Radiat Biol Relat Stud Phys Chem Med 23:235-246
36. Sutherland RM (1988) Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240:177-184
37. Sutherland RM (1998) Tumor hypoxia and gene expression-implications for malignant progression and therapy. Acta Oncol 37:567-574
38. Taghian A, Ramsay J, Allalunis-Turner J (1993) Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 25:243-249
39. Van Bree C, Castro Kreder N, Loves WJ, Franken NA, Peters GJ, Haveman J (2002) Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines. Int J Radiat Oncol Biol Phys 54:237-244
40. Weller M, Streffer J, Wick W, et al (2001) Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma. Cancer 91:423-427